Filing Details

Accession Number:
0001437749-19-012300
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-19 17:16:09
Reporting Period:
2019-06-19
Accepted Time:
2019-06-19 17:16:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1548187 Soliton Inc. SOLY Surgical & Medical Instruments & Apparatus (3841) 364729076
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627363 Remeditex Ventures Llc 2727 N. Harwood Street, Suite 200
Dallas TX 75201
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-19 357,143 $0.00 8,938,516 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy) Acquisiton 2019-06-19 250,000 $0.00 250,000 $16.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
250,000 2019-06-19 No 4 P Direct
Footnotes
  1. The common stock and warrant was issued as part of a unit of securities consisting of (i) one share of the Issuer's common stock, and (ii) 0.7 of a warrant to purchase one share of common stock. The offering price of the units was $14.00 per unit.
  2. Remeditex Ventures LLC is the record and beneficial owner of the shares of common stock and the warrant to purchase common stock subject to this Form 4 and shares voting and dispositive power over such securities with Malachite Trust, the majority owner of Remeditex Ventures LLC and Lyda Hill. Ms. Hill is the Trustee of the Malachite Trust. By reason of such relationships, Ms. Hill, the Malachite Trust and Remeditex Ventures LLC may be deemed to share voting and dispositive power over the securities owned directly by Remeditex Ventures LLC. Remeditex Ventures LLC, the Malachite Trust and Lyda Hill each disclaims beneficial ownership of the reported securities except to the extent of its or her pecuniary interest therein.
  3. The warrant expires five years after the effective date of the resale registration statement registering the shares of common stock underlying the warrant, or when such shares may sold without restriction pursuant to Rule 144 of the Securities Act of 1933.